Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124612835 | 12461283 | 5 | F | 20160528 | 20160720 | 20160613 | 20160727 | EXP | JP-009507513-1606JPN003478 | MERCK | 68.00 | YR | M | Y | 72.90000 | KG | 20160727 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124612835 | 12461283 | 1 | PS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 260 MG, ONCE | 260 | MG | A-504K | 21029 | 260 | MG | CAPSULE | 1X | |||
| 124612835 | 12461283 | 2 | SS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 260 MG, ONCE | 260 | MG | A-608P | 21029 | 260 | MG | CAPSULE | 1X | |||
| 124612835 | 12461283 | 3 | SS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 20MG 5 TABLETS | Y | 21029 | 5 | DF | CAPSULE | 1X | |||||
| 124612835 | 12461283 | 4 | SS | TEMODAL | TEMOZOLOMIDE | 1 | Y | 21029 | CAPSULE | ||||||||||
| 124612835 | 12461283 | 5 | SS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 100MG 10 TABLETS | Y | 21029 | 10 | DF | CAPSULE | 1X | |||||
| 124612835 | 12461283 | 6 | SS | TEMODAL | TEMOZOLOMIDE | 1 | Y | 21029 | CAPSULE | ||||||||||
| 124612835 | 12461283 | 7 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | 10 MG, BID | U | 0 | 10 | MG | TABLET | BID | |||||
| 124612835 | 12461283 | 8 | C | RINDERON V | BETAMETHASONE VALERATE | 1 | Oral | 1 MG, TID | U | 0 | 1 | MG | TABLET | TID | |||||
| 124612835 | 12461283 | 9 | C | KYTRIL | GRANISETRON HYDROCHLORIDE | 1 | Oral | 1 MG, QD | U | 0 | 1 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124612835 | 12461283 | 1 | Central nervous system lymphoma |
| 124612835 | 12461283 | 2 | Chemotherapy |
| 124612835 | 12461283 | 3 | Central nervous system lymphoma |
| 124612835 | 12461283 | 4 | Chemotherapy |
| 124612835 | 12461283 | 5 | Central nervous system lymphoma |
| 124612835 | 12461283 | 6 | Chemotherapy |
| 124612835 | 12461283 | 7 | Gastritis prophylaxis |
| 124612835 | 12461283 | 8 | Cerebral oedema management |
| 124612835 | 12461283 | 9 | Prophylaxis of nausea and vomiting |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124612835 | 12461283 | HO |
| 124612835 | 12461283 | LT |
| 124612835 | 12461283 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124612835 | 12461283 | Dizziness | |
| 124612835 | 12461283 | Overdose | |
| 124612835 | 12461283 | Product use issue | |
| 124612835 | 12461283 | Seizure | |
| 124612835 | 12461283 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124612835 | 12461283 | 1 | 20160528 | 20160528 | 0 | |
| 124612835 | 12461283 | 2 | 20160528 | 20160528 | 0 | |
| 124612835 | 12461283 | 3 | 20160529 | 20160529 | 0 | |
| 124612835 | 12461283 | 5 | 20160529 | 20160529 | 0 | |
| 124612835 | 12461283 | 9 | 20160528 | 0 |